HomeCompareCCORF vs JNJ

CCORF vs JNJ: Dividend Comparison 2026

CCORF yields 2.98% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CCORF wins by $4.71M in total portfolio value
10 years
CCORF
CCORF
● Live price
2.98%
Share price
$8.28
Annual div
$0.25
5Y div CAGR
73.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.74M
Annual income
$3,762,451.42
Full CCORF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — CCORF vs JNJ

📍 CCORF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCCORFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CCORF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CCORF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CCORF
Annual income on $10K today (after 15% tax)
$253.55/yr
After 10yr DRIP, annual income (after tax)
$3,198,083.71/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, CCORF beats the other by $3,194,097.72/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CCORF + JNJ for your $10,000?

CCORF: 50%JNJ: 50%
100% JNJ50/50100% CCORF
Portfolio after 10yr
$2.39M
Annual income
$1,883,570.41/yr
Blended yield
78.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CCORF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
1.2
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CCORF buys
0
JNJ buys
0
No recent congressional trades found for CCORF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCCORFJNJ
Forward yield2.98%2.13%
Annual dividend / share$0.25$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR73.9%28%
Portfolio after 10y$4.74M$30.3K
Annual income after 10y$3,762,451.42$4,689.40
Total dividends collected$4.63M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: CCORF vs JNJ ($10,000, DRIP)

YearCCORF PortfolioCCORF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,219$518.74$10,592$272.30+$627.00CCORF
2$12,950$945.82$11,289$357.73+$1.7KCCORF
3$15,631$1,774.38$12,123$472.89+$3.5KCCORF
4$20,206$3,480.77$13,141$629.86+$7.1KCCORF
5$28,933$7,312.82$14,408$846.81+$14.5KCCORF
6$47,977$17,018.42$16,021$1,151.60+$32.0KCCORF
7$97,199$45,864.10$18,122$1,588.22+$79.1KCCORF
8$255,018$151,015.43$20,930$2,228.20+$234.1KCCORF
9$916,811$643,941.78$24,792$3,191.91+$892.0KCCORF
10$4,743,440$3,762,451.42$30,274$4,689.40+$4.71MCCORF

CCORF vs JNJ: Complete Analysis 2026

CCORFStock

Canaccord Genuity Group Inc., a full-service financial services company, provides investment products, and investment banking and brokerage services to institutional, corporate, and private clients. It operates in two segments, Canaccord Genuity Capital Markets and Canaccord Genuity Wealth Management. The Canaccord Genuity Capital Markets segment offers investment banking, advisory, research, merger and acquisition, sales, and trading services. The Canaccord Genuity Wealth Management segment provides wealth management solutions, and brokerage and financial planning services to individual investors, private clients, charities, and intermediaries. The company operates in North America, the United Kingdom, Europe, Asia, Australia, and the Middle East. Canaccord Genuity Group Inc. was founded in 1950 and is headquartered in Vancouver, Canada.

Full CCORF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this CCORF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CCORF vs SCHDCCORF vs JEPICCORF vs OCCORF vs KOCCORF vs MAINCCORF vs ABBVCCORF vs MRKCCORF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.